Abstract
The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P
| Original language | English |
|---|---|
| Pages (from-to) | 635-639 |
| Number of pages | 5 |
| Journal | Clinical Therapeutics |
| Volume | 9 |
| Issue number | 6 |
| Publication status | Published - 1987 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
Cite this
Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril. / Perani, G.; Muggia, C.; Martignoni, A.; Bongarzoni, A.; Radaelli, A.; Testa, F.; Finardi, G.
In: Clinical Therapeutics, Vol. 9, No. 6, 1987, p. 635-639.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Increase in plasma HDL-cholesterol in hypertensive patients treated with enalapril
AU - Perani, G.
AU - Muggia, C.
AU - Martignoni, A.
AU - Bongarzoni, A.
AU - Radaelli, A.
AU - Testa, F.
AU - Finardi, G.
PY - 1987
Y1 - 1987
N2 - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P
AB - The effects of enalapril on plasma lipoproteins were evaluated in an open study of 12 normolipidemic outpatients with mild-to-moderate essential hypertension (World Health Organization stages I and II). After a two-week washout period, during which placebo was given, the patients received 20 to 40 mg/day of enalapril for 16 weeks. Treatment with enalapril was associated with significant increases in levels of HDL cholesterol (mean, 23%; P2 (mean, 43%; P3 also rose (mean, 14%; P
UR - http://www.scopus.com/inward/record.url?scp=0023635119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023635119&partnerID=8YFLogxK
M3 - Article
C2 - 2830973
AN - SCOPUS:0023635119
VL - 9
SP - 635
EP - 639
JO - Clinical Therapeutics
JF - Clinical Therapeutics
SN - 0149-2918
IS - 6
ER -